Previous 10 | Next 10 |
ENGLEWOOD, Colo. , April 30, 2019 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics,...
ENGLEWOOD, Colo., April 25, 2019 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological di...
Zynex ( ZYXI ) manufactures and markets FDA-approved electrotherapy devices and related supplies for the treatment of chronic and acute pain and for muscle rehabilitation. There are several catalysts in play that have and are likely to continue to propel the stock share price higher. Address...
I have been studying how to capture potential gains from the uplisting process. My recent article reviewed the stock price performance of stocks that uplisted in 2018. I combined the statistics with 2017 uplisted stocks and found that 60% of the stocks reviewed had average gains exceeding 10...
ENGLEWOOD, CO / ACCESSWIRE / March 26, 2019 / Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics today anno...
ENGLEWOOD, Colo., March 19, 2019 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological di...
ENGLEWOOD, Colo., March 12, 2019 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diag...
ENGLEWOOD, Colo. , Feb. 28, 2019 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, ...
Zynex, Inc. (ZYXI) Q4 2018 Earnings Conference Call February 26, 2019 4:15 PM ET Company Participants Thomas Sandgaard – Founder, Chairman and Chief Executive Officer Dan Moorhead – Chief Financial Officer Conference Call Participants Jeffrey Cohen – Lade...
Zynex ( OTCQB:ZYXI ): Q4 GAAP EPS of $0.08 in-line. More news on: Zynex, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
4.45%Change Percent:
Zynex Inc. Company Name:
ZYXI Stock Symbol:
OTCMKTS Market:
Zynex Inc. Website:
2024-07-26 16:37:00 ET Shares of pain-management equipment specialist Zynex (NASDAQ: ZYXI) were falling in Friday trading, down as much as 23.4%, before recovering to a 13.4% decline as of 3:25 p.m. EDT. The medical equipment company reported earnings last night that, on a headl...
A look at the top 10 most actives in the United States Selina Hospitality PLC (SLNA) rose 22.6% to $0.0461 on volume of 144,150,002 shares Vintage Wine Estates Inc. (VWE) rose 21.5% to $0.0849 on volume of 35,620,484 shares NVIDIA Corporation (NVDA) rose 2.4% to $115.03 on volume of 35,381,...
Zynex Reports Second Quarter 2024 Financial Results PR Newswire Q2 2024 Revenue Increased 11% to $49.9 Million ENGLEWOOD, Colo. , July 25, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the ma...